Author: Dotan E, Walter LC, Baumgartner J, Browner IS, Burhenn P, Cohen HJ, Extermann M, Ganti AKP, Gross C, Hubbard J, Hughes K, Hurria A, Jagsi R, Keating NL, Kessler E, Korc-Grodzicki B, McKoy JM, O'Connor T, Owusu C, Rosko A, Rupper RW, Schapira L, Stirewalt DL, Shubbiah IM, Tew WP, VanderWalde N, Wildes T, Williams GR, Bergman MA, Zuccarino-Catania G
Year: 2019
AGREE II score: Available
Developer organization: National Comprehensive Cancer Network
Type of cancer: Not disease site specific
Patient population: Adult
Location: International
This is a clinical practice guideline for older patients with cancer. The guideline provides recommendations for comprehensive geriatric assessments, as well as treatment modalities such as surgery, radiation therapy (RT), chemotherapy, and targeted therapy. Disease-specific issues are also addressed for breast cancer, central nervous system cancers, gastrointestinal cancers, genitourinary cancers, gynecological cancers, head and neck cancers, lung cancers, melanoma, and hematologic malignancies.
AGREE II - Quality of Reporting Assessment:
Scope and purpose: 77.8%
Applicability: 39.6%
Stakeholder involvement: 44.4%
Editorial independence: 70.8%
Rigour: 71.9%
Clarity presentation: 69.4%
